Important notification
04.02.2021 To the attention of interested persons Commission Notice – Application of the Union’s pharmaceutical acquis in markets historically dependent […]
04.02.2021 To the attention of interested persons Commission Notice – Application of the Union’s pharmaceutical acquis in markets historically dependent […]
02.02.2021 To the attention of interested persons EMA press release: EMA starts rolling review of REGN-COV2 antibody combination (casirivimab / […]
02.02.2021 To the attention of interested persons EMA press release: First COVID-19 vaccine safety update published download document …
02.02.2021 To the attention of interested persons EMA press release: COVID-19 vaccine safety update (COMIRNATY BioNTech Manufacturing GmbH) download document […]
01.02.2021 To the attention of interested persons EMA press release: Clarification of Comirnaty dosage interval download document …
29.01.2021 To the attention of interested persons Notice on administration of ivermectin as prophylaxis and treatment in Covid-19 Following the […]
19.01.2021 To the attention of interested persons Appointment of a new NAMMD President Starting today, 19 January 2021, Ms. Roxana […]
12.01.2021 To the attention of Romanian manufacturers of medical devices/authorised representatives/importers Using the EUDAMED “actors” registration module and the single […]
12.01.2021 To the attention of interested persons EMA press release: EMA receives application for conditional marketing authorisation of COVID-19 Vaccine […]
08.01.2021 To the attention of interested persons EMA press release: EMA recommends COVID-19 Vaccine Moderna for authorisation in the EU […]